- Home
- MYND vs LVTX Comparison
MYND vs LVTX Comparison
Compare MYND & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- LVTX
- Stock Information
- Founded
- MYND 1998
- LVTX 2016
- Country
- MYND United States
- LVTX Netherlands
- Employees
- MYND N/A
- LVTX N/A
- Industry
- MYND Other Consumer Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- LVTX Health Care
- Exchange
- MYND Nasdaq
- LVTX Nasdaq
- Market Cap
- MYND 38.8M
- LVTX 33.1M
- IPO Year
- MYND 2017
- LVTX 2021
- Fundamental
- Price
- MYND $0.91
- LVTX $1.32
- Analyst Decision
- MYND
- LVTX Hold
- Analyst Count
- MYND 0
- LVTX 3
- Target Price
- MYND N/A
- LVTX $1.75
- AVG Volume (30 Days)
- MYND 16.5K
- LVTX 42.7K
- Earning Date
- MYND 06-17-2025
- LVTX 05-14-2025
- Dividend Yield
- MYND N/A
- LVTX N/A
- EPS Growth
- MYND N/A
- LVTX N/A
- EPS
- MYND N/A
- LVTX N/A
- Revenue
- MYND $267,380,999.00
- LVTX $4,990,000.00
- Revenue This Year
- MYND N/A
- LVTX N/A
- Revenue Next Year
- MYND N/A
- LVTX N/A
- P/E Ratio
- MYND N/A
- LVTX N/A
- Revenue Growth
- MYND N/A
- LVTX N/A
- 52 Week Low
- MYND $0.61
- LVTX $0.85
- 52 Week High
- MYND $3.89
- LVTX $2.52
- Technical
- Relative Strength Index (RSI)
- MYND 59.58
- LVTX 55.48
- Support Level
- MYND $0.83
- LVTX $1.18
- Resistance Level
- MYND $0.90
- LVTX $1.34
- Average True Range (ATR)
- MYND 0.04
- LVTX 0.07
- MACD
- MYND 0.00
- LVTX 0.00
- Stochastic Oscillator
- MYND 91.54
- LVTX 87.50
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.